Mammostrat Test

Jump to: navigation, search
The Mammostrat test, made by Clarient Diagnostic Services, is a genomic test that measures the levels of five certain genes in early-stage, hormone-receptor-positive breast cancer cells.

Research suggests the Mammostrat test eventually may be widely used to help make treatment decisions based on whether the cancer has a low or high risk of coming back (recurrence).

Knowing whether a woman has a high or low risk of early-stage breast cancer coming back might help women and their doctors decide if chemotherapy or other treatments to reduce risk after surgery are needed.

Subtype Of
Genomic tests
Medical Conditions
Breast cancer

Browse doctors performing Mammostrat Test

Browse clinics performing Mammostrat Test